Skip to main content
. 2021 Apr 20;36:1–13. doi: 10.1016/j.jare.2021.04.007

Fig. 3.

Fig. 3

(A) The cell-free PI3Kγ inhibitory activities of 49 hits and two positive inhibitors, IPI-145 and LY294002; (B) the anti-proliferation effects towards multiple tumor cells of 49 hits and two positive inhibitors, IPI-145 and LY294002; (C) the anti-proliferation effects towards multiple tumor cells of JN-KI3 and IPI-145; (D) the anti-proliferation effects towards multiple malignant tumor cells of JN-KI3 with the gradient of concentrations.